<s id="4b02w"><object id="4b02w"></object></s>

<dd id="4b02w"><big id="4b02w"></big></dd>
  • <dd id="4b02w"><track id="4b02w"></track></dd>

    <dd id="4b02w"><noscript id="4b02w"></noscript></dd>
    <dd id="4b02w"><pre id="4b02w"></pre></dd><em id="4b02w"><strike id="4b02w"></strike></em>

      <form id="4b02w"><ruby id="4b02w"></ruby></form>
    1. <th id="4b02w"></th>
      <progress id="4b02w"></progress>
      搜索

      走進德藥

      德州德藥制藥有限公司

       

      地  址:山東省德州市經濟技術開發區東方紅東路6000號
      質量部:0534-2235805  
      營  銷:0534-2623181 0534-2623132 
      市場部:0534-2623060
      辦公室:0534-2105750

      傳  真:0534-2623130

      查看手機官網

      頁面版權所有? 德州德藥制藥有限公司 魯ICP備11020437號 互聯網藥品信息服務資格證書編號:(魯)非經營性-2015-0056 網站建設:中企動力濟南

      ABOUT US

      走進德藥

             德州德藥制藥有限公司前身為山東省德州制藥廠,始建于1971年,是集研發、生產、銷售于一體的綜合性現代化制藥企業。

             公司于2012年整體搬遷至德州市經濟技術開發區,按新版GMP要求建設德藥新區,新區占地面積200畝,建有原料藥到制劑的完備設備設施,擁有一支專業化的研發、生產、銷售隊伍。

             公司堅持走專、精、特、新型企業發展之路。專:專注心腦血管、抗腫瘤藥物發展方向,精:精于緩控釋制劑技術和凍干制劑技術,特:要么第一,要么唯一,做全國銷量第一、全國唯一的獨家產品,新:創新發展,高質量發展。聚焦經營心腦血管藥、抗腫瘤藥、大品種藥物,三大事業部形成三足鼎立之勢,銷售網絡遍布全國。

             公司重點產品:咖啡酸片,全球獨家專利化學藥物,臨床用于升血小板、升白細胞和止血是國內唯一具有循證醫學研究支持的中輕度血小板減少癥維持治療首選口服化藥,打造中國血液系統用藥第一品牌。

             得高寧(10mg硝苯地平緩釋片),打造臨床常用降壓藥首選品牌,緩釋長效,全國銷量第一,國內首仿,質量標準起草單位,國產藥物選用進口緩釋輔

      料,療效更好!公司正在進行緩釋技術向控釋技術的轉型升級,實施新舊動能轉換,在心腦血管領域形成緩控釋產品群。

             億松(富馬酸阿奇霉素片),全球獨家專利藥物,新型水溶性大環內酯類抗生素,口服給藥,輸液療效,治療呼吸道和泌尿系統感染的口服藥。尤其感冒發燒引起的各種炎癥,起效快、不用輸液、口服三天治愈。治療上呼吸道和泌尿系統感染的非限抗類口服藥物。

             注射用培美曲塞二鈉,國家專利產品,工藝先進,是治療肺癌、惡性胸膜間皮瘤的高端產品;注射用艾司奧美拉唑鈉,新上市的山東省科技廳重點專項產品,國家專利,用于胃潰瘍的治療。

             公司擁有雄厚的科技創新能力,是國家高新技術企業、國家新藥研發大平臺示范企業、省級企業技術中心、藥物滲透泵工程研究中心、博士后創新實踐基地,德州醫藥產業聯盟龍頭企業,德州市重點發展的“護航”企業,連續多年榮獲納稅功勛企業。

             公司堅持三個善待:“善待社會、善待員工、善待股東”,提高企業運行質量,履行社會責任,連續多年被評為德州市納稅先進企業。董事長卞建鋼當選為山東省人大代表、享受國務院特殊津貼。

             公司秉承“以德制藥,藥濟民生”的經營理念,努力實現轉型升級,高質量發展,成為政府認可、社會推崇、公眾贊許的優秀制藥企業,擔負起人類治愈疾病、減輕痛苦,提高生活質量的使命。爭做行業百強,創建百年德藥!

       

      Dezhou Deyao Pharmaceutical Co., Ltd., former Dezhou Pharmaceutical

      Factory in Shandong Province, was founded in 1971. It is a comprehensive

      modern pharmaceutical enterprise integrating research, production and sales.

      In 2012, the company relo cated to Dezhou Economic and Technological

      Development Zone. According to the requirements of the new version of GMP,

      the new factory covering an area of 200 mu was built. It has complete equipment and facilities from API to preparations, and a specialized R&D, production

      and sales team.

       

      The company adheres to the direction of specialized, refined, particular and

      innovative enterprise development. Specialty: focus on the development

      direction of cardiovascular and cerebrovascular drugs and anti-tumor drugs.

       Refining: specialize in the sustained and controlled release preparation

      technology and freeze-drying preparation technology. Particular: either the first,

      or the unique, to be the first in the national sales volume and the only exclusive

      product in the country. Innovation: innovative and high-quality development.

      Focusing on the management of cardiovascular and cerebrovascular drugs, anti-tumor drugs, large market volume drugs, the three business

      divisions have formed a three-in-one trend and sales network proliferates the country. 

       

      The company's core products: Caffeic acid Tablets, the world's exclusive patented chemical drugs, clinical use for platelet-raising, leucocyte

      raising and hemostasis, is the unique domestic evidence-based medicine research support for the maintenance treatment of mild

      thrombocytopenia  preferred oral chemical drugs. We devote to creating the Chinese first brand of blood system medicine.

       

      Degaoning (10mg Nifedipine Sustained-release Tablets) used imported sustained-release excipients is to create the clinical commonly used

      antihypertensive drugs preferred brand. As the first generic drug in china, because of its sustained-release long-term, it has proved better

      efficacy and hold the biggest margins. The company is in the process of transforming and upgrading from slow-release technology to

      controlled-release  technology, and implementing the transformation of old and new driving forces to form a product group of controlled-release

      products in the field of cardiovascular and cerebrovascular diseases.

       

      Yisong (Azithromycin Fumarate Tablets), the world's exclusive patent drugs, new water-soluble macrolides antibiotics, is an oral drugs to treat

      respiratory and urinary tract infections. It has the equal curative effect to infusion. Especially for the cold and fever caused by a variety of

      inflammation, the effect is fast. The disease can be cured by oral cure for three days.

       

      Pemetrexed disodium for injection, a national patented product with advanced technology, is a high-end product for the treatment of lung cancer

      and malignant pleural mesothelioma. Esomeprazole Sodium for Injection,the newly lanched product with national patent, is the key special

      project blockbuster of Department of Science & Technology of Shandong province for the treatment of gastric ulcers.

       

      The company has strong scientific and technological innovation ability, is the National High-Technology Enterprise, National New Medicine

      Research Platform Demonstration Enterprises, Provincial Enterprise Technology Center, Drug Osmotic Pump Engineering Research Center,

      Postdoctoral Innovation Practice Base, Dezhou medicine industry leading enterprises alliance, Dezhou key "escort" for the development of

      enterprises, and has won the Tax-Paying Meritorious Enterprise for multiple consecutive years.

       

      The company insists on three kinds of treatment: "Treat the society well, treat the employees well and treat the shareholders well". It strives to 

      improve the operation quality of the enterprise, fulfill the social responsibility , and has been awarded as the Tax-Paying Advanced Enterprise of

      Dezhou for multiple consecutive years. Bian Jiangang, chairman of the board with a special allowance from the state council, was elected as a

      deputy to the Shandong Provincial People's Congress.

       

      Adhering to the business philosophy of " Make good medicine by our conscience, Improve people's health by our medicine", the company strives

      to achieve transformation and upgrading and high-quality development. It has become an excellent pharmaceutical enterprise recognized by the

      government, respected by the society and praised by the public. We must undertake the mission of curing diseases, alleviating suffering and

      improving the quality of life. The company will undertake the mission of curing diseases, alleviating suffering and improving the quality of life and

      strive to become one of the top 100 enterprises in the pharmaceutical industry, make the century dream of  Deyao come true.

       

      野草社区在线高清视频_日本无码免费一区二区三区_国产自产对白一区_2020天堂在线亚洲精品专区